142 related articles for article (PubMed ID: 5232269)
1. Further observations on the effect of dimethyl sulfoxide in patients with generalized scleroderma. (Progressive systemic sclerosis).
Scherbel AL; McCormack LJ; Layle JK
Ann N Y Acad Sci; 1967 Mar; 141(1):613-29. PubMed ID: 5232269
[No Abstract] [Full Text] [Related]
2. Failure of dimethyl sulfoxide in the treatment of scleroderma.
Binnick SA; Shore SS; Corman A; Fleischmajer R
Arch Dermatol; 1977 Oct; 113(10):1398-402. PubMed ID: 911168
[TBL] [Abstract][Full Text] [Related]
3. Discussion paper: methodology and techniques in the evaluation of dimethyl sulfoxide for connective tissue disorders.
Fleischmajer R
Ann N Y Acad Sci; 1975 Jan; 243():393-4. PubMed ID: 1055555
[No Abstract] [Full Text] [Related]
4. ALTERATION OF COLLAGEN IN GENERALIZED SCLERODERMA (PROGRESSIVE SYSTEMIC SCLEROSIS) AFTER TREATMENT WITH DIMETHYL SULFOXIDE: PRELIMINARY REPORT.
SCHERBEL AL; MCCORMACK LJ; POPPO MJ
Cleve Clin Q; 1965 Apr; 32():47-56. PubMed ID: 14288161
[No Abstract] [Full Text] [Related]
5. Dimethyl sulfoxide in scleroderma.
Ehrlich GE; Joseph R
Pa Med; 1965 Dec; 68(12):51-3. PubMed ID: 5856390
[No Abstract] [Full Text] [Related]
6. Bosentan: new indication. Scleroderma and finger ulcers: no tangible efficacy.
Prescrire Int; 2008 Dec; 17(98):238. PubMed ID: 19422150
[TBL] [Abstract][Full Text] [Related]
7. A clinical trial with dimethyl sulfoxide in scleroderma.
Tuffanelli DL
Arch Dermatol; 1966 Jun; 93(6):724-5. PubMed ID: 5326715
[No Abstract] [Full Text] [Related]
8. [About some effects of dimethyl sulfoxide (DMSO) in percutaneous use].
Kappert A
Schweiz Med Wochenschr; 1968 Nov; 98(46):1829-37. PubMed ID: 5705674
[No Abstract] [Full Text] [Related]
9. Dimethyl sulfoxide (DMSO) in clinical dermatology.
Engel MF
South Med J; 1966 Nov; 59(11):1318-9. PubMed ID: 5333579
[No Abstract] [Full Text] [Related]
10. Raynaud, digital ulcers and calcinosis in scleroderma.
Nitsche A
Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
[TBL] [Abstract][Full Text] [Related]
11. [Treatment results with dimethyl sulfoxide in circumscribed scleroderma].
Gärtner R; Flegel H
Dermatol Wochenschr; 1968 Oct; 154(43):1015-22. PubMed ID: 5733089
[No Abstract] [Full Text] [Related]
12. Dimethyl sulfoxide: a review of its use in the rheumatic disorders.
Trice JM; Pinals RS
Semin Arthritis Rheum; 1985 Aug; 15(1):45-60. PubMed ID: 3898376
[No Abstract] [Full Text] [Related]
13. [Treatment of scleroderma with dimethylsulfoxide].
Serggev VP; Zakiev RZ
Vestn Dermatol Venerol; 1976 Mar; (3):70-3. PubMed ID: 961055
[No Abstract] [Full Text] [Related]
14. Ketanserin in the treatment of progressive systemic sclerosis.
Altomare GF; Pigatto PD; Polenghi MM
Angiology; 1988 Jul; 39(7 Pt 1):583-6. PubMed ID: 3408023
[TBL] [Abstract][Full Text] [Related]
15. The effect of percutaneous dimethyl sulfoxide on cutaneous manifestations of systemic sclerosis.
Scherbel AL
Ann N Y Acad Sci; 1983; 411():120-30. PubMed ID: 6576688
[TBL] [Abstract][Full Text] [Related]
16. [Effect of combined treatment with nicotinic acid and DMSO on microcirculatory disorders in systemic scleroderma].
Aliab'eva AP; Mach ES; Balabanova RM
Ter Arkh; 1978; 50(9):105-7. PubMed ID: 705639
[No Abstract] [Full Text] [Related]
17. [Use of dimethylsulfoxide in complex therapy of patients with systemic scleroderma].
Balabanova RM; Aliab'eva AP; Akhnazarova VD; Oskilko TG; Alekberova ZS
Ter Arkh; 1977; 49(11):99-103. PubMed ID: 605410
[No Abstract] [Full Text] [Related]
18. Treatment of scleroderma by Rheomacrodex.
Alani MD
Acta Derm Venereol; 1970; 50(2):137-9. PubMed ID: 4192318
[No Abstract] [Full Text] [Related]
19. Control trials of dimethyl sulfoxide in rheumatoid and collagen diseases.
Alyabyeva AP; Muravyev YuV
Ann N Y Acad Sci; 1983; 411():309-15. PubMed ID: 6576704
[No Abstract] [Full Text] [Related]
20. Low molecular weight dextran in systemic sclerosis and Raynaud's phenomenon.
Dodman B; Rowell NR
Acta Derm Venereol; 1982; 62(5):440-2. PubMed ID: 6183899
[No Abstract] [Full Text] [Related]
[Next] [New Search]
